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Summary 
Background: Public health policy to prevent iron deficiency through food 
fortification or other measures may be disadvantageous to people with hereditary 
hemochromatosis. 
Methods: 2531 women from a cohort of United Kingdom women were typed for 
C282Y and H63D mutations in the hemochromatosis gene. These women completed 
food frequency questionnaires and provided blood for iron status.  
Results: C282Y homozygotes (n=31) had serum ferritin concentrations 2.4 times 
higher (95% confidence interval = 1.9 - 3.1) than wild types (n=1774) but 
heterozygotes (n=726) were not different from wild types. H63D genotype had no 
effect on its own. The effect of heme iron intake (from meat, fish and poultry) was 2.0 
times greater (1.2 - 3.2) on C282Y homozygotes than other groups. Non-heme iron 
had little effect. 
Conclusions: There may be scope for dietary intervention in women homozygous for 
the C282Y mutation. C282Y heterozygotes and H63D homozygotes and 
heterozygotes have similar serum ferritin concentrations to wild type and need not 
reduce their meat intake, other than as part of a normal healthy diet. 
Keywords 
Hemochromatosis, HFE gene, iron overload, dietary iron, hereditary diseases, 
genetics 
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Public health policy to prevent iron deficiency may be disadvantageous for people 
with hereditary hemochromatosis. This is an autosomal recessive disorder in which 
there is iron accumulation as a result of increased dietary absorption. Most patients 
with hereditary hemochromatosis are homozygous for a single mutation (C282Y) of 
the HFE gene.
1
 In the UK over 90% of patients with hemochromatosis have this 
genotype
2
 as do about 1 in 150 people in the general population.
3
 About 15% of the 
population are carriers of C282Y. A second variant, H63D, is also common in the 
general population (carrier frequency about 25%) and may cause iron accumulation if 
present with C282Y. Although the clinical penetrance of homozygosity for C282Y is 
low,
4,5
 those patients where unidentified iron accumulation leads to iron overload may 
develop organ damage leading to arthritis, diabetes mellitus, heart disease, liver 
cirrhosis and hepatocellular carcinoma.
6
 We therefore set out to address the question 
of whether an individual’s response to long-term dietary practice differs according to 
their genotype. Previous research suggests that heme iron (found in meat, fish and 
poultry) should be the focus of this investigation in hemochromatosis.
7
 
 
Methods 
Subjects 
Participants were sampled from the UK Women’s Cohort Study, a cohort of 35,372 
UK women aged 35-69 in 1995. The Cohort was designed to cover a broad range of 
dietary intakes with equal proportions of self-reported vegetarians, fish-eaters and red 
meat-eaters.
8
 15,000 women were randomly selected to receive two cytology brushes 
and asked to return cheek cell samples by post for DNA assays. Potential C282Y 
homozygotes and heterozygotes were then asked to provide blood samples taken at 
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their local general practice or hospital phlebotomy clinic. Another 3000 Cohort 
women were randomly selected to provide blood samples. 
 
Measurements  
Details of DNA extraction and analysis of blood samples for serum ferritin 
concentration are available with the online version of this article. Long-term diet was 
measured using a 217-item food frequency questionnaire
9,10
 based on the one used by 
the UK EPIC study.
11
 Nutrient values for food items, including total iron, were 
derived from standard UK Food Composition tables.
12
 Estimated heme iron intake 
from meat, fish and poultry was based on meat-specific concentrations of heme iron.
13
 
Supplemental intake of vitamins and minerals, including iron, was assessed by 
separate questionnaire. 
 
Statistical methods 
We initially compared C282Y and H63D homozygotes with wild types for log-
transformed serum ferritin, serum iron, unbound iron binding capacity, total iron 
binding capacity, transferrin saturation, and hemoglobin using two-sample t-tests. In 
this exploratory analysis, 99% confidence intervals (CIs) were used as an 
acknowledgement of the multiple testing involved. We used multiple linear regression 
to investigate the relationship between log-transformed serum ferritin concentrations 
and both total iron intake and heme iron intake. Adjustment was made for age, 
genotype, smoking status, blood donor status, menopausal status, body mass index, 
and intakes of total energy, alcohol, Englyst fiber, calcium, non-heme iron, and 
vitamin C, including supplemental intakes of iron, calcium and vitamin C as 
continuous variables. Any influence of genotype on the relationship between heme 
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iron intake and serum ferritin (i.e. the gene-diet interaction) was formally tested by 
adding the appropriate interaction term to the model and using a likelihood ratio test. 
The power calculation is available with the online version of this article.  
 
Ethical approval for the study was obtained from 173 local research ethics committees 
and written consent for DNA analysis was obtained from all individuals taking part.  
 
Results 
Women had a mean age of 53 ± 9 years at recruitment with mean body mass index of 
25 ± 4. Almost all the women were white. Geometric mean total iron intake was 18.0 
mg/day and 0.3 mg/day for heme iron.  
 
Of the 15,000 women contacted for cheek cell screening, 5349 (36%) provided 
cytology brush samples. Of the 3000 women contacted solely for blood, 1877 (63%) 
returned blood samples. Combining the results from cheek cell and blood samples, 
C282Y and H63D genotype information was available for 6747 (93%) and 6766 
(94%), respectively, of the subjects returning samples. Of those successfully 
genotyped, 31 subjects (0.5%) were homozygous for the C282Y mutation, 901 
(13.4%) were heterozygous for the C282Y mutation, and 5815 (86.2%) were wild 
type for the C282Y mutation. 167 (2.5%) were homozygous for the H63D mutation, 
1745 (25.8%) were heterozygous for the H63D mutation, and 4854 (71.7%) were wild 
type for H63D. Of those who were heterozygous for either C282Y or H63D, 173 
subjects were heterozygotes for both (compound heterozygotes). HFE genotypes were 
consistent with Hardy-Weinberg equilibrium, and phase analysis confirmed the two 
variants to be segregating on distinct haplotypes.  
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There were 2573 analyzable blood samples, with 2531 successfully typed for C282Y 
(31 homozygous, 726 heterozygous, 1774 wild types) and 2535 successfully typed for 
H63D (41 homozygous, 662 heterozygous, 1832 wild types). Blood iron status on 
these subjects is shown by genotype in Table 1. Twelve of the 31 (39%) women 
homozygous for the C282Y mutation had serum ferritin concentrations above the 
upper limit of the reference range. This was a substantially higher proportion than the 
17 (2%) of heterozygotes and 18 (1%) of wild types with blood measurements. Of the 
C282Y homozygotes, 28 (90%) had transferrin saturation above 50%, compared with 
191 (27%) of heterozygotes and 181 (10%) of wild types with this measure.  
 
Adjusting for the potential confounders listed, an increment of 1 mg/day in heme iron 
intake (equivalent to approximately doubling intake) was associated with a 41% 
increase in serum ferritin concentrations (95% CI = 32% - 51%). Being homozygote 
for C282Y was associated with serum ferritin concentrations 2.4 times higher (1.9 - 
3.1) than the wild type. C282Y heterozygotes had similar serum ferritin 
concentrations to wild type (ratio = 1.06; 0.99 - 1.13). The effect of the heme iron 
intake was 2.0 times greater (1.2 - 3.2) for C282Y homozygotes than other groups, 
indicating a statistically significant gene-diet interaction (p=0.006). C282Y 
homozygotes also still had higher ferritin concentrations overall. Serum ferritin 
concentrations predicted by the model for each woman are shown in Figure 1. The 
stronger relationship between heme iron intake and serum ferritin for the C282Y 
homozygotes illustrates the interaction effect. Estimates of the interaction remained 
essentially unchanged after adjustment for socio-economic status and highest 
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educational level. Exclusion of self-reported vegetarians did not substantially change 
the results. There were insufficient data to investigate any threshold effect. 
 
After adjustment for confounding factors, there was no evidence of subjects 
homozygous for H63D having higher serum ferritin concentrations than wild type 
(ratio = 0.97; 0.74 - 1.27). No interaction was evident with H63D genotype (P=0.23). 
Compound heterozygotes (heterozygote for both C282Y and H63D) had serum 
ferritin concentrations 1.2 times higher (1.0 - 1.5) than subjects who were wild type 
for both mutations. 
 
When we investigated total iron intake we found no substantial association with 
serum ferritin concentrations. Only the heme iron component appeared to be related to 
serum ferritin concentration. 
 
Discussion 
We characterized blood iron status in relation to both genotype and dietary iron 
intakes in a large cohort. The estimated prevalences of the mutations were similar to 
previous published studies of hemochromatosis in the United Kingdom,
3,14
 northern 
Europe,
15,16
 and the United States.
4
 If we define biochemical expression of hereditary 
hemochromatosis as serum ferritin concentrations above the upper limit of the 
reference range, then penetrance of this disease in our cohort was 39% (though we 
have no measure of morbidity in this study).  
 
The relative roles of heme and non-heme iron are discussed further in the online 
version of this article, along with a comparison of intakes recorded in other studies. 
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Heme iron intake was strongly related to iron status. Women consuming more heme 
iron had higher serum ferritin concentrations. This relationship was exacerbated by 
homozygosity for the C282Y mutation; the influence of heme iron intake was more 
than twice as strong among C282Y homozygotes than wild types. This resulted in 
substantially raised serum ferritin concentrations in this group. In contrast, even the 
highest intakes of heme iron were not associated with excessive serum ferritin 
concentrations among women who were wild type or heterozygous for C282Y. The 
presence of the H63D mutation was not associated with higher serum ferritin 
concentrations except in those who were compound heterozygotes with the C282Y 
mutation. 
 
These findings confirm results from a series of small studies investigating heme and 
non-heme iron absorption in controlled conditions.
7
 Lynch et al. found in healthy 
volunteers that absorption of both heme and non-heme iron was lower among those 
with higher serum ferritin concentrations. In patients with hemochromatosis, 
absorption of both types of iron was higher, but only heme iron absorption was free of 
any inverse association with serum ferritin. In their study, absorption of iron from 
normal diets in heterozygotes appeared little different from healthy volunteers. We 
have also formally demonstrated the observation of Rossi et al.
17
 that there is no 
difference in serum ferritin concentrations between wild type and heterozygous 
C282Y meat-eaters. 
  
Women who are homozygous for the C282Y mutation should be advised to limit their 
meat (heme iron) intake to reduce the rate of iron accumulation, providing they are 
not anaemic. The larger group of women who are heterozygous for the C282Y 
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mutation do not have substantially higher serum ferritin concentrations than wild type 
and need not reduce their intake on the basis of this study, other than as part of a 
normal healthy diet.   
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Figure legend 
 
Figure 1. Plot of predicted serum ferritin concentrations for regression model 
including genotype by heme iron interaction. 
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Table 1.  Iron status by genotype for 2528 women returning blood samples.  
    C282Y mutation  H63D mutation  Compound 
heterozygote 
 
Genotype 
 Reference 
range 
 C282Y / 
C282Y 
(n=31)* 
C282Y / WT 
 
(n=726)* 
WT / WT 
 
(n=1774)* 
 H63D / 
H63D 
(n=41)* 
H63D / WT 
 
(n=662)* 
WT / WT 
 
(n=1832)* 
 C282Y / 
H63D 
(n=137)* 
Serum ferritin (g/l); mean† 
(95% CI) 
 12-250  131 
(83 - 204) 
55 
(52 - 58) 
44 
(43 - 46) 
 44 
(35 - 57) 
48 
(45 - 51) 
48 
(46 - 50) 
 64 
(56 - 75) 
Serum iron (mol/l); mean 
(95% CI) 
 11-29  34 
(31 - 37) 
22 
(22 - 23) 
20 
(20 - 21) 
 23 
(21 - 25) 
22 
(21 - 23) 
21 
(20 - 21) 
 25 
(23 - 26) 
Unbound Iron Binding Capacity 
(mol/l); mean (95% CI) 
 23-65  13 
(10 - 16) 
30 
(30 - 31) 
36 
(35 - 36) 
 32 
(29 - 36) 
33 
(32 - 33) 
35 
(34 - 35) 
 26 
(25 - 28) 
Total Iron Binding Capacity 
(mol/l); mean (95% CI) 
 54-80  47 
(45 - 49) 
53 
(52 - 53) 
56 
(56 - 57) 
 55 
(53 - 58) 
55 
(54 - 55) 
55 
(54 - 56) 
 51 
(50 - 52) 
Transferrin saturation (%); 
mean (95% CI) 
 ≤ 50  73 
(67 - 79) 
43 
(42 - 44) 
37 
(36 - 37) 
 42 
(38 - 46) 
41 
(40 - 42) 
38 
(38 - 39) 
 49 
(46 - 51) 
Hemoglobin (g/dl); mean (95% 
CI) 
 11.5-16.0  14.5 
(14.0 - 15.0) 
13.9 
(13.8 - 14.0) 
13.6 
(13.5 - 13.6) 
 13.9 
(13.5 - 14.2) 
13.7 
(13.6 - 13.7) 
13.7 
(13.6 - 13.7) 
 14.0 
(13.8 - 14.2) 
Total dietary iron (mg/day); 
Mean† (95% CI) 
 -  16.7 
(14.2 - 19.6) 
18.0 
(17.6 - 18.5) 
17.9 
(17.7 - 18.1) 
 18.3 
(17.2 - 19.3) 
18.0 
(17.7 - 18.4) 
17.9 
(17.7 - 18.1) 
 18.1 
(17.2 - 19.1) 
Dietary heme iron (mg/day); 
Mean† (95% CI) 
 -  0.19 
(0.09 - 0.44) 
0.25 
(0.22 - 0.29) 
0.29 
(0.27 - 0.30) 
 0.37 
(0.28 - 0.49) 
0.29 
(0.27 - 0.32) 
0.28 
(0.26 - 0.29) 
 0.30 
(0.22 - 0.41) 
* Numbers of people with each genotype refer to sampled individuals providing blood and do not reflect proportions in the general population. 
† Geometric mean 
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